GeneDx Corp.

88.50
-3.70 (-4.01%)
At close: Mar 31, 2025, 3:59 PM
88.00
-0.56%
After-hours: Mar 31, 2025, 07:19 PM EDT

Company Description

GeneDx Holdings Corp. is a patient centered health intelligence company.

It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.

The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs.

The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Corp.
GeneDx  Corp. logo
Country United States
IPO Date Nov 4, 2020
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 1,000
CEO Katherine A. Stueland

Contact Details

Address:
North Tower
Stamford, Connecticut
United States
Website http://www.genedx.com

Stock Details

Ticker Symbol WGS
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001818331
CUSIP Number 81663L200
ISIN Number US81663L2007
Employer ID 85-1966622
SIC Code 8000

Key Executives

Name Position
Katherine A. Stueland President, Chief Executive Officer & Director
Dr. Bryan M. Dechairo Ph.D. Chief Operating Officer
Heidi C. Chen J.D. Chief Legal Officer
Kevin Feeley CPA Chief Financial Officer
Eric Olivares Ph.D. Chief Product & Technology Officer
Jami Biliboaca Head of People Strategy
Melanie Duquette Chief Growth Officer
Paul Kruszka FACMG, M.D., M.P.H. Chief Medical Officer
Sabrina Dunbar Chief of Staff

Latest SEC Filings

Date Type Title
Mar 28, 2025 4 Filing
Mar 28, 2025 4 Filing
Mar 17, 2025 4 Filing
Mar 17, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 04, 2025 4 Filing
Feb 21, 2025 SCHEDULE 13D/A [Amend] Filing
Feb 20, 2025 S-8 POS Filing
Feb 20, 2025 S-8 POS Filing